Rosetta Genomics Gains CLIA Certification in Three More States | GenomeWeb

NEW YORK (GenomeWeb News) – MicroRNA diagnostics company Rosetta Genomics said today that it has received Clinical Laboratory Improvement Amendments certification in three states.

The Rehovot, Israel-based company said that it has passed the survey for CLIA certification in California, Rhode Island, and Maryland to conduct molecular diagnostic tests at its Rosetta Laboratories, bringing the total number of states from which it has received CLIA certification to 48.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.